ORG Wealth Partners LLC Grows Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

ORG Wealth Partners LLC raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 423.6% in the 1st quarter, Holdings Channel reports. The fund owned 1,178 shares of the exchange traded fund’s stock after purchasing an additional 953 shares during the period. ORG Wealth Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $92,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Demars Financial Group LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $280,309,000. BlueCrest Capital Management Ltd acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $138,051,000. Mirae Asset Securities USA Inc. grew its stake in shares of SPDR S&P Biotech ETF by 66.7% during the fourth quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after acquiring an additional 600,000 shares in the last quarter. Bessemer Group Inc. increased its position in shares of SPDR S&P Biotech ETF by 5.7% during the fourth quarter. Bessemer Group Inc. now owns 1,376,834 shares of the exchange traded fund’s stock worth $123,997,000 after acquiring an additional 73,866 shares during the last quarter. Finally, RA Capital Management L.P. acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $110,615,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $82.38 on Friday. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47. The stock has a 50-day moving average price of $80.22 and a 200 day moving average price of $85.72. The company has a market capitalization of $4.88 billion, a P/E ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.